Celera Group Summary
Celera Group, a molecular diagnostics business, engages in the
identification and validation of diagnostic markers using proprietary
genomics and proteomics discovery platforms. The company, through its
strategic alliance with Abbott Laboratories, discovers, develops, and
commercializes in vitro diagnostic products for disease detection,
prediction of disease predisposition, disease progression monitoring,
and therapy selection.
Executives
Tony White - Chairman, CEO, President
